Boothbay Fund Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-71,489
| Closed | -$224K | – | 2219 |
|
|
2022
Q1 | $224K | Hold |
71,489
| – | – | 0.01% | 1439 |
|
|
2021
Q4 | $229K | Sell |
71,489
-40,555
| -36% | -$130K | 0.01% | 1251 |
|
|
2021
Q3 | $376K | Sell |
112,044
-29,389
| -21% | -$98.6K | 0.01% | 1014 |
|
|
2021
Q2 | $553K | Buy |
141,433
+9,599
| +7% | +$37.5K | 0.02% | 827 |
|
|
2021
Q1 | $530K | Buy |
+131,834
| New | +$530K | 0.02% | 741 |
|
|
2020
Q2 | – | Sell |
-58,368
| Closed | -$174K | – | 953 |
|
|
2020
Q1 | $174K | Sell |
58,368
-17,370
| -23% | -$51.8K | 0.01% | 581 |
|
|
2019
Q4 | $314K | Sell |
75,738
-3,657
| -5% | -$15.2K | 0.03% | 506 |
|
|
2019
Q3 | $257K | Buy |
+79,395
| New | +$257K | 0.02% | 517 |
|